ConTIPI Medical and EVERSANA Launch Non-Surgical ProVate Device for Pelvic Organ Prolapse in the U.S.

Introduction

In a significant advancement in women's health, ConTIPI Medical has partnered with EVERSANA to introduce ProVate, a groundbreaking non-surgical device aimed at assisting women suffering from pelvic organ prolapse (POP). This device provides an innovative solution for managing pelvic floor dysfunctions, allowing women to regain their confidence and improve their quality of life.

The Solution: ProVate

ProVate is a ready-to-use, disposable device that women can conveniently use at home. It is designed for vaginal insertion and is packaged within an applicator akin to a menstrual tampon applicator. This thoughtful design empowers women by allowing them to take control of their health in a comfortable manner. The device is available in six different sizes, accommodating a range of needs and ensuring a personalized fit for each user.

For up to seven days of use, ProVate offers flexibility. Women can remove it easily at any time using a simple pull string, ensuring disposal is hassle-free. This level of convenience is essential for women who often juggle multiple responsibilities, giving them a discreet and effective option for managing their condition.

Significance of the Launch

The launch of ProVate marks a pivotal moment in the landscape of women's health in the United States. Dr. Elan Ziv, CEO and Medical Director at ConTIPI Medical, expressed excitement about the commercialization of ProVate, stating, "Today marks a significant milestone in women's health as we are thrilled to see ProVate available for physicians to prescribe for patients with pelvic organ prolapse." This innovation provides women with more comprehensive options for addressing their health concerns outside traditional surgical methods.

Partnership with EVERSANA

The collaboration with EVERSANA has been pivotal for ConTIPI in bringing ProVate to market. EVERSANA, renowned for its commercial services in the life sciences sector, assists with pricing strategies, reimbursement processes, market access, and medical communications. Jim Lang, CEO of EVERSANA, highlighted the complexity of launching a new product, indicating that their comprehensive commercial approach has been instrumental in facilitating this milestone.

Looking Ahead

ConTIPI Medical is committed to improving the lives of women encountering various pelvic floor dysfunctions. With this launch, they aim to raise awareness about POP and the available solutions, empowering women to seek help and reclaim their health. To learn more about ProVate and how it can assist in managing pelvic organ prolapse, visit ConTIPI Medical’s official website.

Conclusion

As women's health continues to evolve, products like ProVate are essential in expanding the options available to women facing pelvic organ prolapse. This innovative device not only champions the concept of self-care but also represents a crucial shift towards non-invasive treatments that prioritize women's health and autonomy. With the support of EVERSANA's experienced team, ConTIPI Medical is poised to make a lasting impact in the healthcare market for women.